• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic].

作者信息

Jáuregui Edwin

机构信息

ASOREUMA, Reumatología, Riesgo de fractura S.A-CAYRE IPS, Bogotá, Colombia.

出版信息

Rev Colomb Reumatol. 2021 Apr-Jun;28(2):156-158. doi: 10.1016/j.rcreu.2020.05.004. Epub 2020 Jun 10.

DOI:10.1016/j.rcreu.2020.05.004
PMID:40477029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7284280/
Abstract
摘要

相似文献

1
[Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic].[抗疟药（氯喹和羟氯喹）在2019冠状病毒病大流行中的应用]
Rev Colomb Reumatol. 2021 Apr-Jun;28(2):156-158. doi: 10.1016/j.rcreu.2020.05.004. Epub 2020 Jun 10.
2
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.氯喹或羟氯喹预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 12;2(2):CD013587. doi: 10.1002/14651858.CD013587.pub2.
3
Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review.氯喹和羟氯喹耳毒性对 COVID-19 治疗的临床意义：小型综述。
Front Public Health. 2020 May 29;8:252. doi: 10.3389/fpubh.2020.00252. eCollection 2020.
4
Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19.氯喹和羟氯喹治疗 COVID-19 的疗效。
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4539-4547. doi: 10.26355/eurrev_202004_21038.
5
Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials.氯喹和羟氯喹在2019冠状病毒病中的应用及其心血管影响：理解安全性差异以改进临床试验的解读与设计
Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008688. doi: 10.1161/CIRCEP.120.008688. Epub 2020 May 21.
6
Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak.新冠疫情期间羟氯喹和氯喹的视网膜安全性问题
Int Ophthalmol. 2021 Feb;41(2):719-725. doi: 10.1007/s10792-020-01593-0. Epub 2020 Sep 18.
7
Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19.羟氯喹和氯喹：治疗 COVID-19 的潜在且具争议性的药物。
Arch Pharm Res. 2020 Aug;43(8):765-772. doi: 10.1007/s12272-020-01258-7. Epub 2020 Aug 1.
8
What can visual caregivers expect with patients treated for SARS-CoV-2? An analysis of ongoing clinical trials and ocular side effects.对于接受新型冠状病毒治疗的患者，视力护理人员可以期待什么？对正在进行的临床试验和眼部副作用的分析。
Eur J Ophthalmol. 2021 Mar;31(2):291-303. doi: 10.1177/1120672120958323. Epub 2020 Oct 8.
9
Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine - from HIV-1 infection to COVID-19.将知名药物重新用于抗病毒治疗：羟氯喹和氯喹——从 HIV-1 感染到 COVID-19。
Expert Rev Anti Infect Ther. 2020 Nov;18(11):1119-1133. doi: 10.1080/14787210.2020.1792291. Epub 2020 Jul 13.
10
Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol.COVID-19 药物治疗的心脏安全性：综述及建议监测方案。
Eur Heart J Acute Cardiovasc Care. 2020 Apr;9(3):215-221. doi: 10.1177/2048872620922784. Epub 2020 May 6.

本文引用的文献

1
Emerging prophylaxis strategies against COVID-19.针对新型冠状病毒肺炎的新兴预防策略。
Monaldi Arch Chest Dis. 2020 Mar 30;90(1). doi: 10.4081/monaldi.2020.1289.
2
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
3
A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19.一项关于氯喹治疗 COVID-19 的疗效和安全性的系统评价。
J Crit Care. 2020 Jun;57:279-283. doi: 10.1016/j.jcrc.2020.03.005. Epub 2020 Mar 10.
4
[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].《磷酸氯喹治疗新型冠状病毒肺炎专家共识》
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):185-188. doi: 10.3760/cma.j.issn.1001-0939.2020.03.009.
5
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
6
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.突破：磷酸氯喹在临床研究中显示出对 COVID-19 相关肺炎的明显疗效。
Biosci Trends. 2020 Mar 16;14(1):72-73. doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.
7
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.瑞德西韦和氯喹在体外能有效抑制新出现的新型冠状病毒（2019 - 新冠病毒）。
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.
8
Comparison of the antiviral activity in vitro of some non-steroidal anti-inflammatory drugs.
J Gen Virol. 1969 Mar;4(2):203-14. doi: 10.1099/0022-1317-4-2-203.